Protein kinase inhibitor-based cancer therapies: Considering the potential of nitric oxide (NO) to improve cancer treatment

MLA

Ali Bettaieb, et al. “Protein Kinase Inhibitor-Based Cancer Therapies: Considering the Potential of Nitric Oxide (NO) to Improve Cancer Treatment.” Biochemical Pharmacology, vol. 176, Nov. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....12f0ae42be59febc5f2ec7ea5e5f147a&authtype=sso&custid=ns315887.

APA

Ali Bettaieb, Silvia Ghione, Catherine Paul, Stéphanie Plenchette, & Nesrine Mabrouk. (2019). Protein kinase inhibitor-based cancer therapies: Considering the potential of nitric oxide (NO) to improve cancer treatment. Biochemical Pharmacology, 176.

Chicago

Ali Bettaieb, Silvia Ghione, Catherine Paul, Stéphanie Plenchette, and Nesrine Mabrouk. 2019. “Protein Kinase Inhibitor-Based Cancer Therapies: Considering the Potential of Nitric Oxide (NO) to Improve Cancer Treatment.” Biochemical Pharmacology 176 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....12f0ae42be59febc5f2ec7ea5e5f147a&authtype=sso&custid=ns315887.